Cureverse
Seoul
About Cureverse
Galaxy operates a pharmaceutical research and development company for the treatment of encephalopathy and oncology diseases. The company focuses on creating remedies for challenging brain conditions like dementia, thereby assisting healthcare professionals in enhancing human well-being and overall quality of life.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $5.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2022)
- Website: cureverse.co.kr
Industries & Categories
Biotechnology, Life Science, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cureverse-30210 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.